Status:
COMPLETED
Agreement Between Standard and Continuous Wireless Vital Sign Measurements
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Postoperative Patients
Eligibility:
All Genders
60-110 years
Brief Summary
Patients undergoing major surgery are at risk of postoperative complications. Continuous wireless monitoring outside the post-anesthesia or intensive care units may enable early detection of patient d...
Detailed Description
Patients undergoing major surgery are at risk of postoperative complications. Complications may be preceded by abnormal vital signs. Standard monitoring at general wards is intermittent and manual, le...
Eligibility Criteria
Inclusion
- ≥60 years, scheduled for major abdominal cancer surgery with planned PACU admission.
- Estimated surgical intervention duration ≥2 hours.
Exclusion
- Implanted cardioverter defibrillator or pacemaker, allergy to study devices, severe cognitive impairment assessed by Mini-Mental State Examination ≤24, or inability to cooperate in wearing the wireless monitoring equipment.
Key Trial Info
Start Date :
December 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 22 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05325814
Start Date
December 18 2019
End Date
July 22 2020
Last Update
April 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, Center for Cancer and Organ Diseases
Copenhagen, Denmark, 2100